These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10476886)

  • 21. A novel class of calcium-entry blockers: the 1[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines.
    Gubin J; Lucchetti J; Mahaux J; Nisato D; Rosseels G; Clinet M; Polster P; Chatelain P
    J Med Chem; 1992 Mar; 35(6):981-8. PubMed ID: 1552511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery and SAR of novel tetrahydropyrrolo[3,4-c]pyrazoles as inhibitors of the N-type calcium channel.
    Winters MP; Subasinghe N; Wall M; Beck E; Brandt MR; Finley MF; Liu Y; Lubin ML; Neeper MP; Qin N; Flores CM; Sui Z
    Bioorg Med Chem Lett; 2014 May; 24(9):2053-6. PubMed ID: 24726802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, syntheses, and SAR of 2,8-diazaspiro[4.5]decanones as T-type calcium channel antagonists.
    Fritch PC; Krajewski J
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6375-8. PubMed ID: 20934333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-methyl-D-aspartate receptor antagonists and channel blockers have different effects upon a spinal seizure model in mice.
    McAllister KH
    Eur J Pharmacol; 1992 Jan; 211(1):105-8. PubMed ID: 1535594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
    Mortell KH; Anderson DJ; Lynch JJ; Nelson SL; Sarris K; McDonald H; Sabet R; Baker S; Honore P; Lee CH; Jarvis MF; Gopalakrishnan M
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1138-41. PubMed ID: 16380257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium channel antagonist peptides define several components of transmitter release in the hippocampus.
    Gaur S; Newcomb R; Rivnay B; Bell JR; Yamashiro D; Ramachandran J; Miljanich GP
    Neuropharmacology; 1994 Oct; 33(10):1211-9. PubMed ID: 7862257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity relationships of omega-conotoxins MVIIA, MVIIC and 14 loop splice hybrids at N and P/Q-type calcium channels.
    Nielsen KJ; Adams D; Thomas L; Bond T; Alewood PF; Craik DJ; Lewis RJ
    J Mol Biol; 1999 Jun; 289(5):1405-21. PubMed ID: 10373375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mixed Ca2+ channel blocker, A-1264087, utilizes peripheral and spinal mechanisms to inhibit spinal nociceptive transmission in a rat model of neuropathic pain.
    Xu J; Chu KL; Zhu CZ; Niforatos W; Swensen A; Searle X; Lee L; Jarvis MF; McGaraughty S
    J Neurophysiol; 2014 Jan; 111(2):394-404. PubMed ID: 24155005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (S)-4-Methyl-2-(methylamino)pentanoic acid [4, 4-bis(4-fluorophenyl)butyl]amide hydrochloride, a novel calcium channel antagonist, is efficacious in several animal models of pain.
    Song Y; Bowersox SS; Connor DT; Dooley DJ; Lotarski SM; Malone T; Miljanich G; Millerman E; Rafferty MF; Rock D; Roth BD; Schmidt J; Stoehr S; Szoke BG; Taylor C; Vartanian M; Wang YX
    J Med Chem; 2000 Sep; 43(19):3474-7. PubMed ID: 11000000
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthesis and biological evaluation of novel N3-substituted dihydropyrimidine derivatives as T-type calcium channel blockers and their efficacy as analgesics in mouse models of inflammatory pain.
    Teleb M; Zhang FX; Huang J; Gadotti VM; Farghaly AM; AboulWafa OM; Zamponi GW; Fahmy H
    Bioorg Med Chem; 2017 Mar; 25(6):1926-1938. PubMed ID: 28233679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery and optimization of a novel series of pyrazolyltetrahydropyran N-type calcium channel (Ca
    Wall MJ; Subasinghe NL; Winters MP; Lubin ML; Finley MFA; Qin N; Brandt MR; Neeper MP; Schneider CR; Colburn RW; Flores CM; Sui Z
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3780-3783. PubMed ID: 30337231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of novel neuronal voltage-dependent calcium channel blockers based on emopamil left hand as a bioactive template.
    Suzuki Y; Yamamoto N; Iimura Y; Kawano K; Kimura T; Nagato S; Ito K; Komatsu M; Norimine Y; Kimura M; Teramoto T; Kaneda Y; Hamano T; Niidome T; Yonaga M
    Bioorg Med Chem Lett; 2003 Mar; 13(5):919-22. PubMed ID: 12617921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of seizures in mice by intracerebroventricular administration of the calcium channel agonist BAY k 8644.
    Shelton RC; Grebb JA; Freed WJ
    Brain Res; 1987 Feb; 402(2):399-402. PubMed ID: 2435367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and structure-activity relationship of substituted 1,2,3,4-tetrahydroisoquinolines as N-type calcium channel blockers.
    Yuen P; Schelkun RM; Szoke B; Tarczy-Hornoch K
    Bioorg Med Chem Lett; 1998 Sep; 8(18):2415-8. PubMed ID: 9873552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers.
    Siegrist R; Pozzi D; Jacob G; Torrisi C; Colas K; Braibant B; Mawet J; Pfeifer T; de Kanter R; Roch C; Kessler M; Moon R; Corminboeuf O; Bezençon O
    J Med Chem; 2016 Dec; 59(23):10661-10675. PubMed ID: 27933950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity relationship study of 1,4-dihydropyridine derivatives blocking N-type calcium channels.
    Yamamoto T; Niwa S; Ohno S; Onishi T; Matsueda H; Koganei H; Uneyama H; Fujita S; Takeda T; Kito M; Ono Y; Saitou Y; Takahara A; Iwata S; Shoji M
    Bioorg Med Chem Lett; 2006 Feb; 16(4):798-802. PubMed ID: 16309909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (-)-Phenylalkylamines more potent than (+)-isomers. Further promiscuity of phenylalkylamine Ca2+ antagonists.
    Defeudis FV
    Trends Pharmacol Sci; 1988 Oct; 9(10):352-3. PubMed ID: 3273494
    [No Abstract]   [Full Text] [Related]  

  • 38. Discovery and evaluation of Ca
    Bezençon O; Remeň L; Richard S; Roch C; Kessler M; Ertel EA; Moon R; Mawet J; Pfeifer T; Capeleto B
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5326-5331. PubMed ID: 29074257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain.
    Bowersox SS; Gadbois T; Singh T; Pettus M; Wang YX; Luther RR
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1243-9. PubMed ID: 8968347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The structure-activity relationship study on 2-, 5-, and 6-position of the water soluble 1,4-dihydropyridine derivatives blocking N-type calcium channels.
    Yamamoto T; Niwa S; Ohno S; Tokumasu M; Masuzawa Y; Nakanishi C; Nakajo A; Onishi T; Koganei H; Fujita S; Takeda T; Kito M; Ono Y; Saitou Y; Takahara A; Iwata S; Shoji M
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4813-6. PubMed ID: 18684623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.